Business Blockbuster - Helpng business to be more visible on Google

Business Daily Media


.

Marketing application of BOGUTAI® (teriparatide injection) has been officially accepted by the China National Medical Products Administration (NMPA)

HONG KONG SAR - EQS Newswire - 29 June 2022 - A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (the "Company", together with its subsidiaries, the "Group"; Stock code: 00690.HK) is pleased to announce that t the marketing application submitted by the Group's self-developed BOGUTAI® (teriparatide injection) has been accepted by the China National Medical Products Administration ("NMPA") on 28 June 2022, with the acceptance number "CXSS2200062国".

If BOGUTAI® is approved for marketing, it will provide patients with better drug choices, which is a major milestone for the company in the field of orthopedic diseases.

BOGUTAI® (teriparatide injection) is the Group's fifth marketed product following GENETIME® , GENESOFT® , PINUP® , BOKANGTAI®, and it is also the first domestic manufactured PTH Liquid in China to use a disposable injection pen. Developed in collaboration with Swiss self-care giant Ypsomed, this product has an extremely thin injection needle and high dose accuracy, which can greatly reduce the pain of injections for patients. The Group strongly believe BOGUTAI® will be a future blockbuster for the Group by virtue of the product's strong cost advantage, better therapeutic effect and convenient administration method.

Teriparatide injection adopts biological expression technology, and is a recombinant human parathyroid hormone analog (PTH1-34), which has the same sequence as the 34-amino acid N-terminal amino acid (biologically active region) of human parathyroid hormone of 84 amino acids. For the treatment of osteoporosis in postmenopausal women with a high risk of fractures, it is the only osteogenesis-promoting anti-osteoporosis drug approved for marketing at home and abroad, which can effectively improve bone microstructure, increase bone strength, promote bone healing, and significantly reduce the risk of vertebral and nonvertebral fractures in postmenopausal women.

China is the country with the largest number of osteoporosis in the world. According to the data of the seventh census in 2021, there are currently 264.02 million people aged 60 and above in my country, accounting for 18.70%. Epidemiological surveys show that the prevalence of osteoporosis among people over 50 years old in China is 20.7% for women and 14.4% for men; the prevalence of osteoporosis among people over 60 years old is significantly higher, and women are particularly prominent, as high as 51.6%. Hence, there are currently about 90 million osteoporosis patients in China, and the osteoporosis market size is about 15 billion to 20 billion yuan. The current market share of teriparatide is only about 1% of the PRC osteoporosis market, which is significantly lower than that of foreign countries. The main reason is that it is expensive and not covered by medical insurance. However, in the long run, with the aging of Chinese's population, the gradual improvement of the coverage of the medical insurance system and the improvement of residents' purchasing power, the market size of teriparatide will accelerate significant. Moreover, BOGUTAI's product positioning of being more cost-effective and safe fits the needs of target demographic better, ensuring faster growth compared to other teriparatide competitors.

About Uni-Bio Science Group

Uni-Bio Science Group Limited is principally engaged in the research and development, manufacture and distribution of biopharmaceutical products. The research and development center is fully equipped with a complete system for the development of genetically-engineered products with a pilot plant test base which is in line with NMPA requirements. The Group has two GMP manufacturing bases in Beijing and Shenzhen. The Group also has a highly efficient commercialization platform and marketing network. The Group focuses on the development of novel treatments and innovative drugs addressing the therapeutic areas of endocrine as diabetes and osteoporosis, ophthalmology and dermatology. Please visit the official website of Uni-Bio Science Group for more information:

#UniBioScienceGroup

News from Asia

Sansiri, Thailand’s Award-Winning Developer, Brings 42 Years of Expertise to Phuket, Supporting Long-Term Property Investment

PHUKET, THAILAND – Media OutReach Newswire – 17 November 2026 – Backed by proven development expertise, established construction quality standards and award-winning property management, Sansiri Pu...

Over 360 electricity distribution professionals meet in Seoul for CIRED’s first major event in the Asia-Pacific region

HONG KONG SAR - Media OutReach Newswire - 17 November 2026 - CIRED's first major event in the Asia-Pacific region took place on 2-3 November in Seoul, on the theme of digital disruption – AI and t...

A decade of changing cameras and personal perspectives at the 2026 XMAGE Awards in Paris

PARIS, FRANCE – Media OutReach Newswire – 17 November 2026 - Ali Al Arbash's "Light & Shadow Across France" is among the works featured in "A Heartwarming World," an exhibition that opened Nov...

Mangroves Documentary Premieres, Exploring How Cities and Wetlands Coexist

SHENZHEN, CHINA – Media OutReach Newswire – 17 November 2026 – Guangdong Radio and Television has unveiled Mangroves, a three-part ecological documentary filmed in 4K ultra-high definition, ahead...

Kling AI Launches Kling Image 4.0 with Photographic Realism and Native 8K Generation

BEIJING, CHINA - Media OutReach Newswire - 17 November 2026 - Kling AI, the AI-powered creative platform, today announced the launch of Kling Image 4.0, its latest image generation model that comb...

Broermann Medical Innovation Award 2026: Three Pioneers of Modern Obesity and Diabetes Therapies Honored

Prof. Svetlana Mojsov, Prof. Dr. Richard DiMarchi, and Prof. Dr. Dr. h.c. Matthias H. Tschöp honored for groundbreaking research on metabolic diseases and obesity therapies...

EBANX and Eneba strengthen partnership in Latin America with 138% YoY growth in payment volume

With Pix, Nequi, and Mercado Pago among the most used payment methods by Eneba’s customers, the operation now covers eight countries in the regionCURITIBA, BRAZIL – Media OutReach Newswire – 13 No...

L’OCCITANE Celebrates 50 Years Of Provençal Craftsmanship With Holiday 2026 Collection

Featuring a creative collaboration with artist Caroline Romain-Desfossés, the Maison marks its golden milestone with a festive collection inspired by the art of gifting. KUALA LUMPUR, MALAYSIA – ...

Yicura BioMed Advances Dual Capital and Industrial Strategy: Completes First Closing of Series B Financing Led by Gobi Partners

Advancing Core Product ICVAX® for HIV & Immunotherapy Pipeline for CancersHONG KONG SAR – Media OutReach Newswire – 13 November 2026 – Yicura BioMed ("Yicura"), a clinical-stage immunotherapy ...

LOCUS-T and My Starfish Foundation Launch Illustrated Cancer Book to Make Cancer Information More Accessible

SHAH ALAM, MALAYSIA – Media OutReach Newswire – 13 November 2026 – Malaysian digital marketing agency LOCUS-T has joined hands with My Starfish Foundation (MSF) to launch What Do We Do Next? ...

Why the secrecy around car insurance?

Every year, millions of Australians receive their car insurance renewal and promise themselves they’ll look at it properly later. Then life gets in ...

Australian workers spend almost an hour a day administering email

Research finds email filing, searching and rework consuming an estimated 58 minutes a day and potentially exposing organisations to millionsAustralian...

Customer Service Is Becoming Part of the Small Business Sales and Marketing Engine

For Customer Service Week, 5-9 October, Thryv is urging small businesses to look beyond generating  enquiries and examine what happens after a custome...

Gift Cards as the gateway to agentic payments

Prepaid and stored value gives consumers the trust and control to try AI shopping agents By Blackhawk Network VP Head of ANZ Kieran Nolan For deca...

Why Data Accumulation Without Governance Undermines Sustainability Goals

In July 2026, Group 2 entities, the second cohort of Australian businesses, began their first reporting period under the mandatory climate disclosur...

Permanent $20,000 Instant Asset Write-Off Gives Small Businesses Greater Planning Certainty

The Federal Government’s decision to permanently legislate the $20,000 instant asset write-off will give eligible small businesses greater certainty...